Clinical Trial Update: The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study

View source ↗

Summary

A completed clinical trial study (MDS-TAO) focused on transplantation outcomes in myelodysplastic syndromes with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Myelodysplastic Syndromes (MDS) | Status: COMPLETED | Results posted: 2023-04-03